
Deflazacort
Deflazacort API (CAS No: 14484-47-0) is carefully manufactured by Amber Lifesciences Pvt. Ltd. in modern GMP and ISO 9001:2015 certified facilities, ensuring excellent purity, batch-to-batch consistency, and compliance with international regulatory standards. Every batch is delivered with a comprehensive Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS), meeting USP/BP pharmacopeial requirements.
Deflazacort is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is widely used in the treatment of conditions such as Duchenne muscular dystrophy (DMD), rheumatoid arthritis, asthma, and various allergic and autoimmune disorders. Our API undergoes stringent quality control procedures and validated manufacturing processes to ensure superior performance in pharmaceutical formulations.
Amber Lifesciences serves pharmaceutical manufacturers, distributors, shippers, traders, and formulation partners across Asia, Europe, the Middle East, and LATAM regions, offering reliable supply networks, expert technical support, and comprehensive regulatory documentation to enable smooth product registration and efficient market entry.
Storage & Transportation
Classified as non-Dangerous Goods. Store at controlled room temperature (20°C to 25°C / 68°F to 77°F), away from light and moisture. Handle using standard precautionary measures during transportation and storage.
CAS No.: | 14484-47-0 |
|---|---|
Synonym: | Calcort, Emflaza |
Mol. formula: | C25H31NO6 |
Mol. Weight: | 441.5 g/mol |
Active Pharmaceutical Ingredient (API) – Not for Direct Human or Veterinary Use.